R
Rose-Laure Indorato
Researcher at Centre national de la recherche scientifique
Publications - 5
Citations - 200
Rose-Laure Indorato is an academic researcher from Centre national de la recherche scientifique. The author has contributed to research in topics: Mitosis & Kinesin. The author has an hindex of 3, co-authored 3 publications receiving 188 citations. Previous affiliations of Rose-Laure Indorato include Claude Bernard University Lyon 1.
Papers
More filters
Journal ArticleDOI
Mitosis persists in the absence of Cdk1 activity when proteolysis or protein phosphatase activity is suppressed
Dimitrios A. Skoufias,Rose-Laure Indorato,Françoise B. Lacroix,Andreas Panopoulos,Robert L. Margolis +4 more
TL;DR: It is concluded that continuous Cdk1 activity is not essential to maintain the mitotic state and that phosphatase activity directed at Cdk 1 substrates is largely quiescent during mitosis.
Journal ArticleDOI
Structure–Activity Relationship of S-Trityl-l-Cysteine Analogues as Inhibitors of the Human Mitotic Kinesin Eg5
Salvatore DeBonis,Dimitrios A. Skoufias,Rose-Laure Indorato,François Liger,Bernard Marquet,Christian Laggner,Benoît Joseph,Frank Kozielski +7 more
TL;DR: An initial structure-activity relationship study on a series of STLC analogues reveals the minimal skeleton necessary for Eg5 inhibition as well as indications of how to obtain more potent analogues.
Journal ArticleDOI
Proteome analysis of apoptosis signaling by S-trityl-L-cysteine, a potent reversible inhibitor of human mitotic kinesin Eg5
Frank Kozielski,Dimitrios A. Skoufias,Rose-Laure Indorato,Yasmina Saoudi,Peter R. Jungblut,Hanne Kolsrud Hustoft,Margarita Strozynski,Bernd Thiede +7 more
TL;DR: Proteome analysis following STLC treatment revealed 33 differentially regulated proteins of various cellular processes, 31 of which can be linked to apoptotic cell death, Interestingly, four identified proteins, chromobox protein homolog, RNA‐binding Src associated in mitosis 68 kDa protein, stathmin, and translationally controlled tumor protein can belinked to mitotic and apoptotic processes.
Journal ArticleDOI
Drug resistance dependent on allostery: A P-loop rigor Eg5 mutant exhibits resistance to allosteric inhibition by STLC
TL;DR: It is predicted that resistance can be overcome by inhibitors that bind to other than the Eg5 loop-L5 binding site having different chemical scaffolds, and that allostery-dependent resistance to Eg5 inhibitors may also occur in cells and may have positive implications in chemotherapy since once diagnosed may be beneficial following cessation of the chemotherapeutic regimen.
Binding stoichiometry and structural model of the HIV-1 Rev/Importin beta complex
Didier Spittler,Rose-Laure Indorato,Elisabetta Boeri Erba,Elise Delaforge,Luca Signor,Simon R. Harris,Isabel Saez,Andrés Palencia,Frank Gabel,Martin Blackledge,Marjolaine Noirclerc-Savoye,Carlo Petosa +11 more
TL;DR: A structural model is generated that suggests that the interaction of Rev with the C-terminal portion of importin-beta resembles that of Importin-alpha's IBB domain, which agrees with previous reports that the IBBdomain can compete with Rev for importin -beta binding.